Taipei, Taiwan

Kung-Tsung Wang


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kung-Tsung Wang in Bifunctional Chelating Agents

Introduction

Kung-Tsung Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the synthesis of bifunctional chelating agents. His innovative work has implications for tumor imaging radiopharmaceuticals, showcasing the intersection of chemistry and medical technology.

Latest Patents

Kung-Tsung Wang holds a patent for a method of synthesizing bifunctional chelating agents-peptides. This invention involves a novel synthesis process for BCA-peptides, utilizing Fmoc-Thr(ol)-Terephthal-Acetal-Amide Resin as the starting material. The method includes coupling various amino acids to create a straight peptide-resin, which is then reacted with iodine to produce a disulfide-containing peptide resin. The cleavage of the peptide from the resin is achieved using TFA, followed by protection through a reaction with octreotide and di-t-butyldicarbonate. The final product is labeled with radioisotope .sup.111 InCl.sub.3 for use in tumor imaging radiopharmaceuticals.

Career Highlights

Kung-Tsung Wang is affiliated with the Institute of Nuclear Energy Research, where he continues to advance his research and development in the field of nuclear medicine. His work is characterized by a commitment to innovation and practical applications in healthcare.

Collaborations

Some of his notable coworkers include Te-Wei Lee and Shui-Tein Chen, who have collaborated with him on various projects related to his research.

Conclusion

Kung-Tsung Wang's contributions to the synthesis of bifunctional chelating agents highlight his role as an influential inventor in the field of chemistry and medical technology. His innovative methods pave the way for advancements in tumor imaging and radiopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…